Children in Bondo, Kenya at a Global WACh research site.
Patricia Pavlinac Kirk Tickell Diarrheal Disease diarrheal deaths in children Shigella Global WACh
November 15, 2017 | Department News

Are We Missing a Critical Window for Preventing Diarrheal Deaths in Children?

By Kate Pfizenmaier / Global WACh

Death from diarrheal disease is entirely preventable yet it remains the second leading cause of death worldwide in children under five. When a child arrives at a clinic with severe diarrhea in a low-income country, say Kenya, what dictates the treatment they get? How do we define the severity of their condition and when do we assume it could be life threatening? 

BIRCH team
Non-Communicable Diseases Diarrheal Disease Tuberculosis Pollution COPD Institute for Health Metrics and Evaluation Lalit Dandona global burden of disease
November 13, 2017 | Health News

Comprehensive Health Study in India Finds Rise of Non-communicable Diseases

By Institute for Health Metrics and Evaluation (IHME)

A new state-by-state health analysis in India finds that over two decades heart- and lung-related conditions, as well as other non-communicable diseases (NCDs), have surpassed infectious diseases, such as diarrhea and tuberculosis, as the nation’s leading killers. The extent of this difference, however, varies significantly among the nation’s 29 states and seven union territories.

Measuring a child
Patricia Pavlinac Judd Walson Diarrheal Disease Global WACh Christine McGrath
August 10, 2016 | Department News

Department Part of Major Study to Test Antibiotics as a Treatment for Diarrheal Disease in High-Risk Children in Low Resource Settings

By Amelia Vader

Researchers at the University of Washington and Kenya Medical Research Institute are working to determine if antibiotics could help save thousands of children from dying of diarrheal disease thanks to a four-year $2.5 million grant from the World Health Organization.

The Antibiotics for Children with Severe Diarrhea (ABCD) Trial is the largest clinical trial addressing diarrhea management to date; and it will not only answer the question of the potential benefits of antibiotics it will also address any potential harm, such as antibiotic resistance.